Profound blockade of T cell activation requires concomitant inhibition of different class I PI3K isoforms
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Profound blockade of T cell activation requires concomitant inhibition of different class I PI3K isoforms
Authors
Keywords
T lymphocyte, PI3K inhibitor, p110 isoform
Journal
IMMUNOLOGIC RESEARCH
Volume 62, Issue 2, Pages 175-188
Publisher
Springer Nature
Online
2015-04-13
DOI
10.1007/s12026-015-8648-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic applications of PI3K inhibitors in cardiovascular diseases
- (2013) Alessandra Ghigo et al. Future Medicinal Chemistry
- Targeting PI3K isoforms and SHIP in the immune system: new therapeutics for inflammation and leukemia
- (2012) Matthew D Blunt et al. CURRENT OPINION IN PHARMACOLOGY
- PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis
- (2012) Simon M. Schultze et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Selective Inhibition of Phosphoinositide 3-Kinase p110α Preserves Lymphocyte Function
- (2012) Lomon So et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- poly(I:C) costimulation induces a stronger antiviral chemokine and granzyme B release in human CD4 T cells than CD28 costimulation
- (2012) Tim Meyer et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
- (2011) Michael C. Schmid et al. CANCER CELL
- Immunotherapy with PI3K Inhibitor and Toll-Like Receptor Agonist Induces IFN- +IL-17+ Polyfunctional T Cells That Mediate Rejection of Murine Tumors
- (2011) N. A. Marshall et al. CANCER RESEARCH
- PI3-Kinase Regulates Eosinophil and Neutrophil Degranulation in Patients with Allergic Rhinitis and Allergic Asthma Irrespective of Allergen Challenge Model
- (2011) Mary Kämpe et al. INFLAMMATION
- Class IA Phosphoinositide 3-Kinase and Regulate Neutrophil Oxidase Activation in Response to Aspergillus fumigatus Hyphae
- (2011) K. B. Boyle et al. JOURNAL OF IMMUNOLOGY
- PI3K Plays a Critical Role in Neutrophil Activation by Immune Complexes
- (2011) S. Kulkarni et al. Science Signaling
- PI3K/p110 is a novel therapeutic target in multiple myeloma
- (2010) H. Ikeda et al. BLOOD
- PI3K p110 regulates T-cell cytokine production during primary and secondary immune responses in mice and humans
- (2010) D. R. Soond et al. BLOOD
- Phosphatidylinositol 3-kinase- inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals
- (2010) S. E. M. Herman et al. BLOOD
- The role of mTOR in memory CD8+ T-cell differentiation
- (2010) Koichi Araki et al. IMMUNOLOGICAL REVIEWS
- Regulation of phosphoinositide 3-kinase expression in health and disease
- (2009) Klaartje Kok et al. TRENDS IN BIOCHEMICAL SCIENCES
- Inhibition of PI3K by ZSTK474 suppressed tumor growth not via apoptosis but G0/G1 arrest
- (2008) Shingo Dan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking
- (2008) Linda V Sinclair et al. NATURE IMMUNOLOGY
- Targeting phosphoinositide 3-kinase—Moving towards therapy
- (2007) Romina Marone et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started